Pharma, Pharmaceutics and Biotechnology Conference

It goes without saying that understanding drug interactions is one of the critical issues involving pharmaceutical care because drug interactions can dramatically impact both patient safety and treatment efficacy.

This session will examine mechanisms of drug interactions, their clinical implications, and the importance of effective management strategies in preventing adverse effects comprehensively.

Drug Interactions: This means the effect of one drug on the pharmacokinetics/pharmacodynamics of another; in other words, competition for therapeutic effects or increased toxicity. In reality, there are fundamentally three classes of interactions: drug-drug, food-drug, and drug-disease. Educating healthcare providers about drug interactions will be crucial as the experts entrusted with the prescription decisions.

Clinical Implication: Mild to major interactions can produce clinical consequences. In class, use actual case studies of clinically significant drug interactions and the consequences associated with those outcomes involving hospitalizations as well as with increased health-care costs.

Participants will learn one common class of interacting drugs and one specific population group at increased risk, particularly elderly patients with multiple comorbid conditions.

Management Strategies: Proactive management strategies are required for effective management of drug interactions. This session will cover best practices on how to assess risk and evaluate drug interaction, including clinical decision support and patient education strategies.

The experts will report on critically important medication reviews, the role of the pharmacist in managing polypharmacy, and the implementation of clinical guidelines for the reduction of risks from drug interactions.

New understandings in drug interaction and their relevance to quality patient care will be gained at the end of this session. Let's all join in on the advancement of our knowledge and skills in identifying, assessing, and managing drug interactions that may impact patient safety and outcomes of therapeutic interventions.